Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective

Email this article to a friend

Current and new antitumor necrosis factor agents in perspective

Ravinder N Maini

Arthritis Res Ther 2004, 6(Suppl 2):S1-S2 doi:10.1186/ar994

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.